Disseminated Mycobacterium tuberculosis infection due to interferon γ deficiency. Response to replacement therapy

Thorax

Volumn 62, Issue 1, 2007, Pages 97-99

  Seneviratne, Suranjith Luke ^a,d   Doffinger, Rainer ^b   Macfarlane, John ^c   Ceron Gutierrez, L ^b   Kashipaz, M R Amel ^a   Robbins, A ^a   Patel, T ^a   Powell, P T ^a   Kumararatne, D S ^b   Powell, Richard J ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12 RECEPTOR; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FEVER; GAMMA INTERFERON DEFICIENCY; HUMAN; KIDNEY TUBERCULOSIS; LOW BACK PAIN; MILIARY TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NEPHRECTOMY; PATIENT COMPLIANCE; PLEURA EFFUSION; PRIORITY JOURNAL; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; FEMALE; HIV SERONEGATIVITY; HUMANS; INTERFERON TYPE II; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 33846261515     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.051649     Document Type: Article

References (6)

1. Lammas DA, Casanova JL, Kumararatne DS. Clinical consequences of defects in the IL-12 dependent interferon-gamma (IFN-γ) pathway. Clin Exp Immunol 2000;121:417-25.
2. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002;20:581-620.
3. Jouanguy E, Doffinger R, Dupuis S, et al. IL-12 and IFN-γ in host defence against mycobacteria and salmonella in mice and men. Curr Opin Immunol 1999;11:346-51.
4. Cooper AM, Dalton DK, Stewart TA, et al. Disseminated tuberculosis in interferon-γ gene disrupted mice. J Exp Med 1993;178:2243-7.
5. Dorman SE, Holland SM. Interferon-γ and IL-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000;11:321-33.
6. Doffinger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-γ in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunily. Clin Infect Dis 2004;38:e10-4.